Aurobindo Pharma gets USFDA nod for sedative drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride in 0.9 per cent sodium chloride injection, 200 µg/50 mL and 400 µg/100 mL single dose flexible containers (bags), Aurobindo Pharma said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3qI6ZPy